Clementia Pharmaceuticals Inc. (NASDAQ: CMTA) today announced the early completion of patient enrollment in the MOVE Trial, Clementia’s registrational Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE